Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 0.0 |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 2.06 | 2.26 |
NAV | ₹16.49 | ₹154.54 |
Fund Started | 12 May 2023 | 13 Oct 2005 |
Fund Size | ₹1537.25 Cr | ₹1433.05 Cr |
Exit Load | Exit load of 1%, if redeemed within 15 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 16.05% | 22.04% |
3 Year | - | 18.28% |
5 Year | - | 21.41% |
1 Year
3 Year
5 Year
Equity | 98.67% | 95.27% |
Cash | 0.05% | 3.36% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Reliance Industries Ltd. | 9.44% |
ITC Ltd. | 8.98% |
HFCL Ltd. | 8.32% |
JIO Financial Services Ltd. | 6.54% |
Samvardhana Motherson International Ltd. | 5.81% |
S.P. Apparels Ltd. | 4.89% |
Life Insurance Corporation of India | 4.59% |
Aurobindo Pharma Ltd. | 4.44% |
Larsen & Toubro Ltd. | 4.14% |
Sun TV Network Ltd. | 3.84% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.53% |
Axis Bank Ltd. | 7.51% |
Reliance Industries Ltd. | 6.13% |
HDFC Bank Ltd. | 5.03% |
Bharti Airtel Ltd. | 4.90% |
State Bank of India | 4.23% |
Bajaj Finserv Ltd. | 4.22% |
NTPC Ltd. | 4.01% |
Infosys Ltd. | 3.73% |
Sun Pharmaceutical Industries Ltd. | 3.44% |
Name | Ankit A Pande | Sri Sharma |
Start Date | 22 Aug 2023 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation by investing with focus on riding business cycles through allocation between sectors and stocks at different stages of business cycles. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 12 May 2023 | 13 Oct 2005 |
Description
Launch Date